SEARCH

SEARCH BY CITATION

References

  • 1
    Schoenberg MP, Gonzalgo ML. Management of Invasive and Metastatic Bladder Cancer. Campbell-Walsh Urology, 9th edn, Vol. 3. Saunders Elsevier, Philadelphia, PA, 2007; 2471.
  • 2
    Culp OS, Utz DC, Harrison EG. Experiences with ureteral carcinoma in situ detected during operations for vesical neoplasm. J. Urol. 1967; 97: 679682.
  • 3
    Sharma TC, Melamed MR, Whitmore WF. Carcinoma in-situ of the ureter in patients with bladder carcinoma treated by cystectomy. Cancer 1970; 26: 583587.
  • 4
    Cooper PH, Waisman J, Johnston WH, Skinner DG. Severe atypia of transitional epithelium and carcinoma of the urinary bladder. Cancer 1973; 31: 10551060.
  • 5
    Skinner DG, Richie JP, Cooper PH, Waisman J, Kaufman JJ. The clinical significance of carcinoma in situ of the bladder and its association with overt carcinoma. J. Urol. 1974; 112: 6871.
  • 6
    Kenworthy P, Tanguay S, Dinney CP. The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter. J. Urol. 1996; 155: 501503.
  • 7
    Osman Y, El-Tabey N, Abdel-Latif M, Mosbah A, Moustafa N, Shaaban A. The value of frozen-section analysis of ureteric margins on surgical decision-making in patients undergoing radical cystectomy for bladder cancer. BJU Int. 2007; 99: 8184.
  • 8
    Stimson CJ, Cookson MS, Barocas DA et al. Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. J. Urol. 2010; 183: 17321737.
  • 9
    Atzpodien J, Royston P, Wandert T, Reitz M. Group D–GCRCC-IT. Metastatic renal carcinoma comprehensive prognostic system. Br. J. Cancer 2003; 88: 348353.
  • 10
    Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 2936.
  • 11
    Johnson DE, Wishnow KI, Tenney D. Are frozen-section examinations of ureteral margins required for all patients undergoing radical cystectomy for bladder cancer? Urology 1989; 33: 451454.
  • 12
    Schumacher MC, Scholz M, Weise ES, Fleischmann A, Thalmann GN, Studer UE. Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder? J. Urol. 2006; 176: 24092413.
  • 13
    Nuhn P, Bastian PJ, Novara G et al. Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery. Urol. Int. 2011; 87: 4248.
  • 14
    Sylvester RJ, van der Meijden AP, Oosterlinck W et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 2006; 49: 4665.
  • 15
    Shariat SF, Zippe C, Lüdecke G et al. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder. J. Urol. 2005; 173: 15181525.
  • 16
    Graefen M, Karakiewicz PI, Cagiannos I et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J. Clin. Oncol. 2002; 20: 32063212.
  • 17
    Sorbellini M, Kattan MW, Snyder ME et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J. Urol. 2005; 173: 4851.
  • 18
    Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J. Clin. Oncol. 2002; 20: 791796.
  • 19
    Karakiewicz PI, Shariat SF, Palapattu GS et al. Precystectomy nomogram for prediction of advanced bladder cancer stage. Eur. Urol. 2006; 50: 12541260.